Page last updated: 2024-08-22

camptothecin and Chronic Lung Injury

camptothecin has been researched along with Chronic Lung Injury in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akahori, D; Amano, T; Hasegawa, H; Kakutani, T; Koda, K; Kunimoto, Y; Matsui, T; Niwa, H; Ozawa, Y; Suda, T; Tanahashi, M; Yamada, K; Yokomura, K1
Hanatate, F; Kobayashi, K; Komaki, C1

Other Studies

2 other study(ies) available for camptothecin and Chronic Lung Injury

ArticleYear
Preexisting Interstitial Lung Disease and Lung Injury Associated with Irinotecan in Patients with Neoplasms.
    Anticancer research, 2018, Volume: 38, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Camptothecin; Female; Follow-Up Studies; Humans; Irinotecan; Lung Diseases, Interstitial; Lung Injury; Male; Middle Aged; Neoplasms; Prognosis; Retrospective Studies; Risk Factors

2018
[A case of drug-induced lung injury associated with chemotherapy (FOLFOX6, FOLFIRI, Bevacizumab) for an advanced colon cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:1

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Colonic Neoplasms; Fatal Outcome; Female; Fluorouracil; Humans; Leucovorin; Lung Injury; Neoplasm Staging; Organoplatinum Compounds; Tomography, X-Ray Computed

2011